Tag:

Nuon Therapeutics

Latest Headlines

Nuon gets $27M to fund a mid-stage trial

April 28, 2008

Frazier Healthcare Ventures and Domain Associates have joined forces to lead a $27 million Series B for Nuon Therapeutics, a San Mateo, CA-based developer working on new therapies for autoimmune and

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Director, Clinical Safety
Daiichi Sankyo - Edison, NJ
Director, Regulatory Affairs
Tesaro - Waltham, MA
Sr. Director, Healthcare Compliance Audit Job
Celgene Corporation - Summit, NJ, US
Entry Level Process Engineer and Lead Process Engineer
Foster Wheeler Biokinetics - San Francisco, CA
Clinical Research Associate / CRA Virology Job
Yoh - Danbury, CT, USA

Nuon Therapeutics

Latest Headlines

Latest Headlines

Nuon gets $27M to fund a mid-stage trial

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Nuon Therapeutics

Latest Headlines

Latest Headlines

Nuon gets $27M to fund a mid-stage trial

Related Tags